---
title: "PTEN"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene PTEN"
tags: ['PTEN', 'TumorSuppressor', 'Cancer', 'Mutation', 'Treatment', 'Prognosis', 'DrugResponse', 'GeneticInformation']
---

# Information about Gene PTEN

## Genetic Position
- Gene: PTEN
- Chromosome: 10
- Location: 10q23.3 (from base pair 88,862,968 to base pair 88,893,488)

## Pathology
PTEN is involved in several cancer types and other diseases. The mutations in the PTEN gene are associated with:

- Cowden syndrome
- Bannayan-Riley-Ruvalcaba syndrome
- PTEN hamartoma tumor syndrome 
- Lhermitte-Duclos disease
- Glioblastoma
- Prostate cancer
- Endometrial cancer

## Function
The PTEN gene is responsible for making a protein called phosphatase and tensin homolog, or PTEN. This protein acts as a tumor suppressor and is involved in regulating cell growth and division. It also plays a role in DNA repair, cell migration, and communication between cells.

## External IDs and Aliases
- HGNC: 9588
- NCBI Entrez: 5728
- Ensembl: ENSG00000171862
- OMIM: 601728
- UniProtKB/Swiss-Prot: P60484
- Aliases: BZS, CWS1, DEC, GLM2, MHAM, PTEN1, MMAC1, MMAC1P1, TEP1

## AA Mutation List and Mutation Type with dbSNP ID
- p.Arg130Gly (rs121912657)
- p.Arg130Trp (rs121912658)
- p.Gly129Ala (rs118203998)
- p.Gly129Cys (rs267607213)
- p.Asp92Asn (rs267607214)
- p.Arg173Cys (rs267607215)
- p.Asp326Tyr (rs267607216)
- p.Asp326Asn (rs267607217)
- p.Leu320Phe (rs267607218)
- Missense mutations

## Somatic SNVs/InDels with dbSNP ID
- c.C33T (rs121912659)
- c.A119T (rs121912660)
- c.C242G (rs121912661)
- c.C296T (rs267607211)
- c.T399G (rs121912663)
- c.C824T (rs121912662)
- Single nucleotide variants and small insertions/deletions

## Related Disease
- Cowden syndrome
- Bannayan-Riley-Ruvalcaba syndrome
- PTEN hamartoma tumor syndrome 
- Lhermitte-Duclos disease
- Autism Spectrum Disorders (ASD)
- Glioblastoma
- Prostate cancer
- Endometrial cancer

## Treatment and Prognosis
Treatment options for diseases associated with PTEN mutations depend on the specific condition and severity of symptoms. In general, treatment may involve surgery, radiation therapy, chemotherapy, medications, or a combination of these approaches. Prognosis varies depending on the disease and individual factors such as age, general health, and response to treatment.

## Drug Response
Several studies have shown that PTEN status may affect the response to certain cancer treatments. For example, PTEN-deficient tumors may be more sensitive to certain chemotherapy agents, while other treatments may be less effective. Targeted therapies designed to inhibit PTEN activity are also being investigated for their potential use in cancer treatment.

## Related Papers
- **Title:** PTEN, more than the AKT pathway
  - **Author:** Di Cristofano, Antonio; Pandolfi, Pier Paolo
  - **DOI:** 10.1038/nrg1671 
- **Title:** PTEN mutations in gliomas and glioneuronal tumors.
  - **Author:** Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R
  - **DOI:** 10.1093/hmg/7.3.463

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**